Chun-Nan Chen

This inventor holds 6 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Single Cell Technology, Inc., Acrobiosystems, Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Nan Chen. Retrieved from https://idiyas.com/inventor/chun-nan-chen-u2t97oxi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 121(Granted Patents)

Company Filing History:

6 out of 6

Single Cell Technology, Inc.

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12116415 - Anti-BCMA antibodies (2024-10-15),

2. 9944983 - Method of screening a plurality of single secreting cells for functional activity (2018-04-17),

3. 9873871 - Method of obtaining antibodies of interest and nucleotides encoding same (2018-01-23),

4. 9328172 - Method of obtaining antibodies of interest and nucleotides encoding same (2016-05-03),

5. 8309317 - Method of screening single cells for the production of biologically active agents (2012-11-13),

6. 8309035 - Multi-well system (2012-11-13),

Title: Innovations and Contributions of Inventor Chun-Nan Chen

Introduction

Chun-Nan Chen is a notable inventor based in San Jose, CA, with a significant contribution to the field of biotechnology. He holds a total of 6 patents, showcasing his innovative spirit and dedication to advancing scientific knowledge.

Latest Patents

Among his latest patents, Chun-Nan Chen has developed anti-BCMA antibodies, which are designed to recognize the B-Cell Maturation Antigen (BCMA) and provide methods of use for these antibodies. Additionally, he has created a method for screening a plurality of single secreting cells for functional activity. This invention relates to methods, devices, and kits that measure the amount of reporter gene mRNA produced in response to secreted molecules, thereby assessing their functional activity.

Career Highlights

Chun-Nan Chen has worked with several prominent companies in the biotechnology sector, including Single Cell Technology, Inc. and Acrobiosystems, Inc. His work in these organizations has contributed to the development of innovative solutions in the field.

Collaborations

Chun-Nan Chen has collaborated with notable individuals such as James O Bowlby, Jr. and Richard Aleck Jorgensen, further enhancing his contributions to the field through teamwork and shared expertise.

Conclusion

Chun-Nan Chen's innovative work and patents reflect his commitment to advancing biotechnology. His contributions have the potential to impact various applications in the medical and scientific communities.

Profile summary based on public USPTO records.